![]() Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases. | ![]() Praxis Precision Medicines Praxis Precision Medicines is a company that develops therapies intended for patients and families affected by complex and debilitating brain disorders. | ||||
Founding Date | Founding Date 2016 | Founding Date 2013 | Founding Date 2017 | Founding Date 2017 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Redwood City, US HQ Boston, US | Locations Cambridge, US HQ Smithfield, US | Locations Watertown, US HQ Cambridge, US | Locations Boston, US HQ | Locations Cambridge, US HQ |
Employees | Employees 1438% increase | Employees 17423% increase | Employees 207 | Employees 891% increase | Employees 11641% increase |
Valuation ($) | Valuation ($) 116.2 m | Valuation ($) 7.5 m | Valuation ($) 3.1 b | Valuation ($) N/A | Valuation ($) 1.3 b |
Financial | |||||
Net income | Net income ($116.8m) (FY, 2025) | Net income ($179.7m) (FY, 2022) | Net income ($311.4m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 145.6m | Total funding raised $ 245m | Total funding raised $ 197m | Total funding raised $ 50m | Total funding raised $ 131.9m |

Rubius is developing a new class of drugs, Red-Cell Therapeutics™.
View company
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
View company
Praxis Precision Medicines is a company that develops therapies intended for patients and families affected by complex and debilitating brain disorders.
View company